A fast-growing drug discovery company using their pioneering human extracellular matrix (ECM)-based discovery platform to develop a portfolio of programmes in fibrosis and solid tumours.
Skills & Results
A detailed consultancy exercise was undertaken to establish the requirements for creation of a CL2 compliant laboratory & high-quality offices.
Working collaboratively with the client team, the specification & design were developed, tendered & delivered on time & to budget.
The detailed design was co-ordinated & approved via the Landlord team including infrastructure, enabling works & design of MEP services & gas installations.
Despite some delays to the delivery of the project through COVID-19, the client was delighted with the way the project was delivered & the quality of the new facility.